AstraZeneca (AZN)

Add to Watchlists
Create an Alert
63.49 -0.04  -0.06% NYSE Apr 17, 8:00PM BATS Real time Currency in USD

AstraZeneca Enterprise Value:

80.21B for None

View 4,000+ financial data types

View Full Chart

AstraZeneca Enterprise Value Chart

Export Data
Save Image

AstraZeneca Historical Enterprise Value Data

Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
April 17, 2014 80.21B
April 16, 2014 80.26B
April 15, 2014 78.99B
April 14, 2014 78.90B
April 11, 2014 79.09B
April 10, 2014 80.40B
April 9, 2014 81.43B
April 8, 2014 80.22B
April 7, 2014 80.91B
April 4, 2014 81.38B
April 3, 2014 82.16B
April 2, 2014 82.98B
April 1, 2014 82.59B
March 31, 2014 81.96B
March 28, 2014 82.36B
March 27, 2014 82.07B
March 26, 2014 81.33B
March 25, 2014 81.71B
March 24, 2014 80.74B
March 21, 2014 81.03B
March 20, 2014 81.92B
March 19, 2014 83.05B
March 18, 2014 83.58B
March 17, 2014 83.24B
March 14, 2014 82.49B
   
March 13, 2014 82.45B
March 12, 2014 84.21B
March 11, 2014 84.26B
March 10, 2014 84.17B
March 7, 2014 84.55B
March 6, 2014 84.42B
March 5, 2014 85.18B
March 4, 2014 85.87B
March 3, 2014 84.50B
Feb. 28, 2014 85.58B
Feb. 27, 2014 86.36B
Feb. 26, 2014 85.63B
Feb. 25, 2014 85.62B
Feb. 24, 2014 85.94B
Feb. 21, 2014 84.13B
Feb. 20, 2014 84.14B
Feb. 19, 2014 83.09B
Feb. 18, 2014 86.07B
Feb. 14, 2014 85.13B
Feb. 13, 2014 85.29B
Feb. 12, 2014 83.74B
Feb. 11, 2014 82.69B
Feb. 10, 2014 81.37B
Feb. 7, 2014 80.55B
Feb. 6, 2014 79.09B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for
Advertisement

AZN Enterprise Value Benchmarks

Companies
GlaxoSmithKline 149.65B
Pfizer 197.51B
Johnson & Johnson 268.92B

AZN Enterprise Value Range, Past 5 Years

Minimum 50.61B Jun 5 2012
Maximum 86.36B Feb 27 2014
Average 65.44B
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.